Consulting Services for Next-Generation Biotechnology Leaders

CarthaGenetics® provides consulting services to biotechnology firms, pharmaceutical laboratories as well as start-up companies. The company offers personalized services helping such companies enter new markets and launch a variety of innovative products such as : drugs, cell and gene therapies, medical devices, products derived from tissue engineering. The CarthaGenetics® portfolio of consulting services can benefit established firms in Western Europe, as well as benefit any firm willing to expand in the fast-growing MENA (Middle East - North Africa ) markets.

Our client-oriented approach will help you define requirements, needs and goals. A clear management-by-objective (MBO) methodology is applied. In this process, various competences and resources will be required, from multi-skilled global teams to local, feet-in-the-street experts.

CarthaGenetics® was founded in 2004 by Philippe Carteron, on the basis of his ten-year personal commitment to the treatment of « orphan diseases » (rare and mostly genetic diseases) across Europe.

Philippe was able to extend his reach from Europe to North Africa through the continuous support of world-class biotechnology market leaders over all these years. His vision: to improve patients' welfare and reimbursement, to embrace local health policies and accompany their political progress, and to cooperate closely with all Tunisian clinicians. His project: an independent, flexible and proactive organization named CarthaGenetics®.